Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?
Read More Pharma Industry News FDA grants accelerated approval to AstraZeneca’s Calquence for mantle cell lymphoma treatment AstraZeneca has achieved a significant milestone with the early FDA approval of Calquence (acalabrutinib) for the treatment of… bypharmanewsdailyNovember 1, 2017
